Delivering pharmaceuticals to the skin in a sustained release manner (hours to days) with two leading drug development programs in androgenic alopecia and cutaneous lupus.

Atticus Pharma Inc. has developed a silica-based sustained release delivery system for a mitochondrial activator, targeting alopecia with promising results compared to minoxidil. Clinical trials are underway to validate ...